MT-2 (Melanotan II Acetate)

Quick Facts

1. Summary

Melanotan II (MT-2) is an experimental melanocortin receptor agonist originally investigated for its ability to stimulate melanin production and increase skin pigmentation. Unlike Melanotan I (Afamelanotide), MT-2 was never developed into an approved pharmaceutical product and remains an experimental research compound.

Interest in MT-2 primarily centers around cosmetic tanning applications, though the compound is also known to influence appetite regulation, sexual arousal pathways, and other melanocortin-mediated physiological systems. Because these effects extend well beyond pigmentation alone, MT-2 is often associated with a broader side-effect profile than MT-1.

What People Commonly Claim

• Accelerated tanning
• Reduced UV exposure requirements
• Darker pigmentation
• Reduced sunburn susceptibility
• Appetite suppression
• Enhanced libido

What the Literature Actually Shows

• MT-2 clearly stimulates pigmentation pathways.
• Melanocortin receptor activation influences multiple physiological systems beyond skin pigmentation.
• Nausea and flushing are commonly reported adverse effects.
• Darkening of freckles and moles has been documented.
• Serious adverse-event case reports exist.
• Long-term human safety data remain limited.

CKF Transparency Note: MT-2 is one of the most widely discussed peptides in cosmetic tanning communities, but its scientific evidence base is considerably weaker than that of Afamelanotide (MT-1). Much of the current dosing culture surrounding MT-2 originates from community practice rather than controlled clinical research.

2. Reconstitution Guide

At this concentration:
• 250 mcg = 0.050 mL (5.0 units)
• 500 mcg = 0.100 mL (10.0 units)
• 3 mg = 0.600 mL (60.0 units)

3. Typical Research Protocols

CKF Evidence Note: Most commonly discussed MT-2 dosing schedules originate from community practice rather than controlled clinical studies. Unlike MT-1, MT-2 lacks a substantial body of approved clinical research establishing standardized dosing protocols.

4. Mechanism of Action

MT-2 activates melanocortin receptors involved in pigmentation, appetite regulation, sexual-function signaling, and other physiological pathways.

• Increased melanin production
• Enhanced tanning response
• Pigmentation signaling activation
• Appetite-modulation effects
• Sexual-function pathway activation
• Melanocortin receptor stimulation

Because melanocortin receptors are distributed throughout multiple tissues, MT-2 produces a broader range of physiological effects than compounds focused exclusively on pigmentation.

5. Potential Benefits

• Enhanced tanning response
• Reduced required UV exposure
• Increased skin pigmentation
• Potential reduction in sunburn susceptibility
• Possible appetite-suppression effects
• Potential libido-related effects

6. Potential Risks / Side Effects

High

• Nausea
• Vomiting
• Facial flushing
• Fatigue
• Darkening of freckles
• Darkening of existing moles
• Uneven pigmentation
• Priapism (rare but documented)
• Potential abnormal melanocyte signaling concerns
• Limited long-term human safety data

One of the most frequently discussed concerns surrounding MT-2 involves stimulation of melanocytes, the cells responsible for pigment production. While current evidence does not demonstrate that MT-2 causes melanoma, documented pigmentation changes and limited long-term safety data justify ongoing caution and routine monitoring of changing skin lesions.

Published case reports have also documented serious adverse events in some users, highlighting the importance of conservative risk assessment despite the compound’s popularity within tanning communities.

7. Half-Life

MT-2 is commonly reported as having a plasma half-life of approximately 30–60 minutes.

Despite this relatively short circulating duration, pigmentation effects typically accumulate gradually through repeated melanocyte stimulation and interaction with ultraviolet exposure.

Visible tanning effects therefore often persist substantially longer than measurable circulating peptide levels.

8. Storage Information

• Store refrigerated before and after reconstitution
• Protect from direct light exposure
• Avoid repeated freeze-thaw cycles
• Maintain sterile handling practices during preparation

9. Contraindications / Warnings

• History of melanoma or skin cancer
• Abnormal, changing, or suspicious moles
• Pregnancy or breastfeeding
• Known hypersensitivity to peptide compounds
• Photosensitivity disorders

10. Further Study

Tier 1 — Essential Reading

• Melanotan II (DermNet NZ)
• Melanotan II: A Possible Cause of Renal Infarction
• Melanotan Tanning Injection: A Rare Cause of Priapism

Tier 2 — Advanced Reading

• Changes in Oral Mucosa Associated with Melanotan II Injections
• An Overview of Benefits and Risks of Chronic Melanocortin-1 Receptor Activation
• What is Melanotan II?

Current Evidence Gaps

• Large-scale human clinical trials
• Long-term dermatologic safety studies
• Standardized dosing protocols
• Long-term cancer-risk assessment
• Comparative studies versus Afamelanotide
• Human pharmacokinetic characterization

11. Research References

• PubMed
• PubMed Central (PMC)
• Dermatology literature
• Melanocortin receptor research
• Pigmentation biology literature
• Photobiology and UV-response research

12. Last Reviewed

June 2026